I know for a fact that the GTC order preventing shares from being borrowed is a fallacy. The only positions not eligible to be loaned out exist in a cash only account and even in those occasions the clearing firms are soliciting customers with payments to lend out their shares
Apparently they tried pretty hard yesterday afternoon. What self respecting LONG trader decides to flood the market with stock over a 10-15 minute time frame in a small cap/low float security such as AMPE???? Why would that same trader be so motivated to liquidate a 100k+ position in such a short amount of time with no specific event supposedly causing him to sell??? The answer very simply, absent of news, is NO ONE. IMHO the fundamentals clearly lie on the side of longs and the only thing the shorts can rely on are technicals. Throw enough money at the "problem" and they are capable of producing any result they desire. Shorts will constantly point to the stock price being down as a sign of a #$%$ stock, completely ignoring the fact that they were responsible for taking the stock lower. They need sellers to capitulate and sell for them to ultimately be successful, DON"T SELL. Further Institutional buying, further advancement with the FDA, announcement of potential JV/partnership make this short issue a non-event. Patience will be rewarded here. JMHO
Thx Steve. You're a good short as you simply are trying to make money without exerting any outside influence other than hitting a button. Understand you go long too, you're agnostic. Wish there were more individuals like yourself in this industry
Question. If you believe positive catalysts will occur in 2014 and the stock will be appreciably higher than it is today where should one enter into his position??? the 200SMA around $6.15??? (not sure about the 200sma language but you get my drift)
You're only argument left is time!! You can't argue the science anymore on Ampion (you still have FUD to spread around on Optina but you'll be wrong about that too). Funny thing is those JV/partnership announcements that the CEO mentioned at Piper conference can be announced any day. Would kind of suck to be you if you get caught short on that day. Just sayin"
There is still a decent short position here so defying valuation logic is par for the course when they are involved. Let them play their games, INVESTORS will win in the end
referring to the ONLY problem I see with the company... Inability to garner Institutional support and the subsequent lessoning of volatility it would provide. I'm on the good guy's side here
So the stock gets punished by some 25% because of a 14% reduction in Medicare reimbursement for a product the company hasn't even produced any revenue from yet, correct???????????
Make sense to me....... Not!!!
You guys are both right. I will side a little more on Ed's side simply because the company barely had 15 minutes to speak and needed to get to the selling points that mattered to the perspective buyers. Those perspective buyers that were present probably didn't need to be educated on FDA timelines or designations and probably needed to hear more about how Ampion is better than current remedies and the potential an approved Ampion has in the marketplace. Just my $.02
We need Institutional support to counter-act the shorts using AMPE as a play-toy. We also need a broader Institutional base to mitigate the effects of any Institution wanting to sell. Doesn't take much to move this stock
The FDA seemed to like the data and they apparently are the entity that counts the most. The likes of you are irrelevant in the grand scheme of things
Not a big Institutional following yet and a very motivated short hedge fund will have that effect on a stock price. Time should take care of both of those topics
Listen to the presentation today. It's on their website. CEO stated the obvious.. we're talking to over 8 interested parties that are interested in JV'ing, outright buying Ampion. He also stated they are entertaining the idea of taking the drug all the way through approval themselves. I believe the "immediate gratification" crowd along with the shorts are focusing on this comment. Another day in the life of WS
If there ever was a time an Investor needed to ignore the daily/weekly/monthly fluctuations of a stock it is here and now. AMPE is attempting to get the word out about their accomplishments (See Piper conference) and with that hopefully get Institutions to become shareholders. This process takes time and the hedge funds that are short this stock know that and they will create all kinds of volatility to induce fear and selling. AMPE is nearing the finish line with Ampion and the revenue prospects are enormous for OAK (See Syn-visc annual $500MM) and the competition less than stellar( See AAOS advisory to quit using hyaluronic (???) acid drugs). This drug is worth a heck of a lot more than $7.80 per share and I believe in time that will be proven. Will it happen next week or month or even 1st Qtr 2014???? Who knows and I don't really care. Hedge Fund's, with their $2 Trillion of buying power, have mastered the art of manipulating stock prices. It doesn't take much money to move AMPE stock around if you don't have buyers fighting back on the other side. Buy the dips and realize what you own. See OMED today and look at the chart. ALL MHO only
Not wanting to be a lying sc**bag like the shorts, this headline was pulled from a poster on Stocktwits. Not sure exactly what their introduction headline says for their presentation. My apologies for my premature excitement. Maybe I could use some Zertane!!
Here's the title of the Piper conference tomorrow:
Piper - Investors conference on Tues. Does Ampion have a potential "regrowth" "regenerative" story? Updates on MRI's? Ask CEO.
I wonder what those updated MRI's look like?? We'll know soon enough